Nucana Plc Adr stock is traded at $0.93, with a volume of 14,567. It is down -0.43% in the last 24 hours and down -14.68% over the past month. NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.
Previous Close:
$0.934
Open:
$0.9482
24h Volume:
14,567
Relative Volume:
0.58
Market Cap:
$3.87M
Revenue:
-
Net Income/Loss:
-$41.08M
P/E Ratio:
-
EPS:
-$33.32
Net Cash Flow:
-$9.93M
1W Performance:
-7.92%
1M Performance:
-14.68%
6M Performance:
-57.92%
1Y Performance:
-74.45%
1-Day Range:
$0.9018$0.95
1-Week Range:
$0.9$1.09
52-Week Range:
$0.9$4.55
Nucana Plc Adr Stock (NCNA) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS